Premium
Genome wide analysis of pathogenic SH2 domain mutations
Author(s) -
Lappalainen Ilkka,
Thusberg Janita,
Shen Bairong,
Vihinen Mauno
Publication year - 2008
Publication title -
proteins: structure, function, and bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.699
H-Index - 191
eISSN - 1097-0134
pISSN - 0887-3585
DOI - 10.1002/prot.21970
Subject(s) - biology , sh2 domain , genetics , mutation , gene , bruton's tyrosine kinase , proto oncogene tyrosine protein kinase src , cancer research , signal transduction , tyrosine kinase
The authors have made a genome‐wide analysis of mutations in Src homology 2 (SH2) domains associated with human disease. Disease‐causing mutations have been detected in the SH2 domains of cytoplasmic signaling proteins Bruton tyrosine kinase (BTK), SH2D1A, Ras GTPase activating protein (RasGAP), ZAP‐70, SHP‐2, STAT1, STAT5B, and the p85α subunit of the PIP3. Mutations in the BTK , SH2D1A , ZAP70 , STAT1 , and STAT5B genes have been shown to cause diverse immunodeficiencies, whereas the mutations in RASA1 and PIK3R1 genes lead to basal carcinoma and diabetes, respectively. PTPN11 mutations cause Noonan sydrome and different types of cancer, depending mainly on whether the mutation is inherited or sporadic. We collected and analyzed all known pathogenic mutations affecting human SH2 domains by bioinformatics methods. Among the investigated protein properties are sequence conservation and covariance, structural stability, side chain rotamers, packing effects, surface electrostatics, hydrogen bond formation, accessible surface area, salt bridges, and residue contacts. The majority of the mutations affect positions essential for phosphotyrosine ligand binding and specificity. The structural basis of the SH2 domain diseases was elucidated based on the bioinformatic analysis. Proteins 2008. © 2008 Wiley‐Liss, Inc.